Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
173 hedge funds and large institutions have $1.15B invested in Amedisys in 2015 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 13 closing their positions.
373% more call options, than puts
Call options by funds: $8.65M | Put options by funds: $1.83M
238% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 13
22% more funds holding
Funds holding: 142 → 173 (+31)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $1.17B → $1.15B (-$18.9M)
2% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 58
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$23.7M |
| 2 |
DCM
Decade Capital Management
New York
|
-$15M |
| 3 |
Millennium Management
New York
|
-$11.1M |
| 4 |
GAM
Gotham Asset Management
New York
|
-$10.9M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.84M |
AMED Hedge Fund Activity: Q3 2015 in Review
173 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2015, worth a combined $1.15B — down 1.6% from $1.17B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new AMED positions and 13 closed out — a net gain of 31 holders — while 57 added to existing stakes and 58 trimmed.
The largest buyer was BlackRock Advisors, adding an estimated $21.5M. The largest seller was Fidelity Investments, cutting an estimated $23.7M.
- 173 institutional investors held Amedisys (AMED) as of Q3 2015, up from 142 in Q2 2015.
- Funds reported $1.15B of Amedisys stock for Q3 2015, down 1.6% quarter-over-quarter.
- 44 funds opened new Amedisys positions in Q3 2015 and 13 closed out, a net change of +31 holders.
- The largest Amedisys buyer in Q3 2015 was BlackRock Advisors, an estimated $21.5M added.
- The largest Amedisys seller in Q3 2015 was Fidelity Investments, an estimated $23.7M sold.
Based on aggregated 13F filings for Q3 2015.